Annual Total Liabilities
$30.87 B
+$8.16 B+35.95%
31 December 2023
Summary:
Novo Nordisk A/S annual total liabilities is currently $30.87 billion, with the most recent change of +$8.16 billion (+35.95%) on 31 December 2023. During the last 3 years, it has risen by +$17.38 billion (+128.90%). NVO annual total liabilities is now at all-time high.NVO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$41.48 B
+$4.60 B+12.49%
30 September 2024
Summary:
Novo Nordisk A/S quarterly total liabilities is currently $41.48 billion, with the most recent change of +$4.60 billion (+12.49%) on 30 September 2024. Over the past year, it has increased by +$12.14 billion (+41.40%). NVO quarterly total liabilities is now at all-time high.NVO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.0% | +41.4% |
| 3 y3 years | +128.9% | +146.2% |
| 5 y5 years | +242.0% | +293.4% |
NVO Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +128.9% | at high | +146.2% |
| 5 y | 5 years | at high | +242.0% | at high | +306.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Novo Nordisk A/S Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $41.48 B(+12.5%) |
| June 2024 | - | $36.87 B(+27.4%) |
| Mar 2024 | - | $28.93 B(-6.3%) |
| Dec 2023 | $30.87 B(+35.9%) | $30.87 B(+5.2%) |
| Sept 2023 | - | $29.33 B(+5.6%) |
| June 2023 | - | $27.77 B(+11.5%) |
| Mar 2023 | - | $24.91 B(+9.7%) |
| Dec 2022 | $22.71 B(+20.5%) | $22.71 B(+3.4%) |
| Sept 2022 | - | $21.96 B(+8.3%) |
| June 2022 | - | $20.28 B(+3.5%) |
| Mar 2022 | - | $19.60 B(+4.0%) |
| Dec 2021 | $18.84 B(+39.7%) | $18.84 B(+11.8%) |
| Sept 2021 | - | $16.84 B(+13.8%) |
| June 2021 | - | $14.81 B(+13.3%) |
| Mar 2021 | - | $13.07 B(-3.1%) |
| Dec 2020 | $13.49 B(+32.3%) | $13.49 B(+6.4%) |
| Sept 2020 | - | $12.67 B(+10.4%) |
| June 2020 | - | $11.48 B(+8.1%) |
| Mar 2020 | - | $10.61 B(+4.1%) |
| Dec 2019 | $10.20 B(+13.0%) | $10.20 B(-3.3%) |
| Sept 2019 | - | $10.54 B(+6.8%) |
| June 2019 | - | $9.88 B(+4.6%) |
| Mar 2019 | - | $9.44 B(+4.6%) |
| Dec 2018 | $9.03 B(+6.6%) | $9.03 B(+6.7%) |
| Sept 2018 | - | $8.46 B(+0.7%) |
| June 2018 | - | $8.40 B(+3.1%) |
| Mar 2018 | - | $8.15 B(-3.7%) |
| Dec 2017 | $8.47 B(+13.9%) | $8.47 B(+5.0%) |
| Sept 2017 | - | $8.06 B(+6.1%) |
| June 2017 | - | $7.60 B(-1.9%) |
| Mar 2017 | - | $7.74 B(+4.2%) |
| Dec 2016 | $7.43 B(+13.2%) | $7.43 B(+7.3%) |
| Sept 2016 | - | $6.92 B(+1.4%) |
| June 2016 | - | $6.83 B(-0.3%) |
| Mar 2016 | - | $6.85 B(+4.4%) |
| Dec 2015 | $6.57 B(+9.4%) | $6.57 B(+3.4%) |
| Sept 2015 | - | $6.35 B(+0.1%) |
| June 2015 | - | $6.34 B(-3.5%) |
| Mar 2015 | - | $6.57 B(+9.5%) |
| Dec 2014 | $6.00 B(+16.8%) | $6.00 B(+5.7%) |
| Sept 2014 | - | $5.68 B(+14.9%) |
| June 2014 | - | $4.94 B(-9.5%) |
| Mar 2014 | - | $5.46 B(+6.3%) |
| Dec 2013 | $5.14 B(+15.8%) | $5.14 B(-2.1%) |
| Sept 2013 | - | $5.25 B(+3.8%) |
| June 2013 | - | $5.06 B(+2.7%) |
| Mar 2013 | - | $4.92 B(+10.9%) |
| Dec 2012 | $4.44 B(-6.5%) | $4.44 B(-17.2%) |
| Sept 2012 | - | $5.36 B(+8.1%) |
| June 2012 | - | $4.96 B(-3.9%) |
| Mar 2012 | - | $5.16 B(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $4.75 B(+8.9%) | $4.75 B(-2.1%) |
| Sept 2011 | - | $4.85 B(+1.8%) |
| June 2011 | - | $4.77 B(+3.9%) |
| Mar 2011 | - | $4.59 B(+5.2%) |
| Dec 2010 | $4.36 B(+19.2%) | $4.36 B(+4.1%) |
| Sept 2010 | - | $4.19 B(+8.9%) |
| June 2010 | - | $3.84 B(-0.2%) |
| Mar 2010 | - | $3.85 B(+5.4%) |
| Dec 2009 | $3.66 B(+10.3%) | $3.66 B(+4.9%) |
| Sept 2009 | - | $3.49 B(+7.8%) |
| June 2009 | - | $3.23 B(-3.5%) |
| Mar 2009 | - | $3.35 B(+1.1%) |
| Dec 2008 | $3.32 B(+8.9%) | $3.32 B(+4.5%) |
| Sept 2008 | - | $3.17 B(-2.6%) |
| June 2008 | - | $3.26 B(-5.1%) |
| Mar 2008 | - | $3.44 B(+12.8%) |
| Dec 2007 | $3.05 B(+18.2%) | $3.05 B(+4.3%) |
| Sept 2007 | - | $2.92 B(+8.2%) |
| June 2007 | - | $2.70 B(-0.1%) |
| Mar 2007 | - | $2.70 B(+4.8%) |
| Dec 2006 | $2.58 B(+13.6%) | $2.58 B(-2.0%) |
| Sept 2006 | - | $2.63 B(+7.8%) |
| June 2006 | - | $2.44 B(+5.3%) |
| Mar 2006 | - | $2.31 B(+2.0%) |
| Dec 2005 | $2.27 B(+13.2%) | $2.27 B(+3.7%) |
| Sept 2005 | - | $2.19 B(+11.6%) |
| June 2005 | - | $1.96 B(+4.5%) |
| Mar 2005 | - | $1.88 B(-6.4%) |
| Dec 2004 | $2.00 B(+28.9%) | $2.00 B(+20.9%) |
| Sept 2004 | - | $1.66 B(+8.5%) |
| June 2004 | - | $1.53 B(-5.1%) |
| Mar 2004 | - | $1.61 B(+3.5%) |
| Dec 2003 | $1.56 B(+28.7%) | $1.56 B(+28.7%) |
| Dec 2002 | $1.21 B(+16.5%) | $1.21 B(+16.5%) |
| Dec 2001 | $1.04 B(-6.0%) | $1.04 B(-6.0%) |
| Dec 2000 | $1.10 B(+3.4%) | $1.10 B(+3.4%) |
| Dec 1999 | $1.07 B(-26.8%) | $1.07 B(-26.8%) |
| Dec 1998 | $1.46 B(+32.3%) | $1.46 B(+32.3%) |
| Dec 1997 | $1.10 B(+4.6%) | $1.10 B(+4.6%) |
| Dec 1996 | $1.05 B(+2.1%) | $1.05 B(+2.1%) |
| Dec 1995 | $1.03 B(-21.5%) | $1.03 B(-21.5%) |
| Dec 1994 | $1.31 B(+22.2%) | $1.31 B(+22.2%) |
| Dec 1993 | $1.08 B(+8.2%) | $1.08 B(+8.2%) |
| Dec 1992 | $994.29 M(+1.9%) | $994.29 M(+1.9%) |
| Dec 1991 | $975.82 M(+3.1%) | $975.82 M(+3.1%) |
| Dec 1990 | $946.22 M(+15.9%) | $946.22 M(+15.9%) |
| Dec 1989 | $816.44 M(+51.8%) | $816.44 M(+51.8%) |
| Dec 1988 | $537.70 M(+5.8%) | $537.70 M(+5.8%) |
| Dec 1987 | $508.19 M(-8.4%) | $508.19 M(-8.4%) |
| Dec 1986 | $554.52 M(+103.3%) | $554.52 M(+103.3%) |
| Dec 1985 | $272.73 M(+21.2%) | $272.73 M(+21.2%) |
| Dec 1984 | $225.10 M | $225.10 M |
FAQ
- What is Novo Nordisk A/S annual total liabilities?
- What is the all time high annual total liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual total liabilities year-on-year change?
- What is Novo Nordisk A/S quarterly total liabilities?
- What is the all time high quarterly total liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly total liabilities year-on-year change?
What is Novo Nordisk A/S annual total liabilities?
The current annual total liabilities of NVO is $30.87 B
What is the all time high annual total liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total liabilities is $30.87 B
What is Novo Nordisk A/S annual total liabilities year-on-year change?
Over the past year, NVO annual total liabilities has changed by +$8.16 B (+35.95%)
What is Novo Nordisk A/S quarterly total liabilities?
The current quarterly total liabilities of NVO is $41.48 B
What is the all time high quarterly total liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total liabilities is $41.48 B
What is Novo Nordisk A/S quarterly total liabilities year-on-year change?
Over the past year, NVO quarterly total liabilities has changed by +$12.14 B (+41.40%)